外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用

doi:10.16352/j.issn.1001-6325.2022.06.001

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (6): 871-875.doi: 10.16352/j.issn.1001-6325.2022.06.001

外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用

武坤¹, 聂波², 李云涛², 杨金荣², 程沈菊¹, 李艳红¹, 史明霞^2*

昆明医科大学第一附属医院 1.医学检验科; 2.血液科,云南昆明 650032

收稿日期:2021-01-11 修回日期:2021-09-03 出版日期:2022-06-05 发布日期:2022-06-02
通讯作者: * shmxia2002@sina.com
基金资助:
国家自然科学基金地区科学基金(81760035); 云南省教育厅科学研究基金(2020J0172); 云南省技术厅科学研究基金[2018FE001(-200)]

Peripheral blood miR-200c level predicts the occurence of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

WU Kun¹, NIE Bo², LI Yun-tao², YANG Jin-rong², CHENG Shen-ju¹, LI Yan-hong¹, SHI Ming-xia^2*

1. Department of Laboratory Medicine; 2. Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming 650032, China

Received:2021-01-11 Revised:2021-09-03 Online:2022-06-05 Published:2022-06-02
Contact: * shmxia2002@sina.com

摘要/Abstract

摘要： 目的探讨外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病(aGVHD)发生的预测作用。方法选择2014年1月至2018年10月在昆明医科大学第一附属医院血液科行异基因造血干细胞移植(Allo-HSCT)的51例患者作为研究对象,根据移植后是否发生aGVHD原则分为实验组(发生aGVHD)33例、对照组(未发生aGVHD)18例。抽取肘部外周血5 mL,RT-qPCR检测两组miR-200c,分析两组miR-200c表达差异。结果两组患者均移植成功,且恢复造血功能,恢复时间为18 d,其中33例发生aGVHD,18例未发生aGVHD,发生率为64.71%;实验组在移植前、移植后7、14、及72 d时,miR-200c表达均低于对照组(P＜0.05);aGVHD发生后外周血中miR-200c显著低于发生前(P＜0.001);与aGVHD Ⅰ度相比,aGVHD Ⅱ度患者外周血中miR-200c表达下调(P＜0.05),与Ⅱ度相比,aGVHD Ⅲ度患者外周血中miR-200c表达下调(P＜0.001);miR-200c高表达组患者2年总生存率高于低表达组(P＜0.05);miR-200c对aGVHD疾病产生诊断价值较好。结论 miR-200c水平降低与异基因造血干细胞移植后aGVHD的发生相关;随着aGVHD严重程度升高miR-200c表达水平降低,miR-200c低表达患者生存率较差。miR-200c可作为早期诊断和预测aGVHD的标志物。

关键词: 急性移植物抗宿主病, miR-200c, 异基因造血干细胞移植, 预后

Abstract: Objective To investigate the predictive function of miR-200c level in peripheral blood on acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation. Methods Fifty-one patients who received allo-HSCT in hematology department of our hospital from January 2014 to October 2018 were selected as the research subjects. According to the principle of whether agVHD occurred after transplantation, 33 patients were in the experimental group (with aGVHD) and 18 patients were in the control group (without aGVHD). RT-qPCR was used to detect miR-200c in two groups and the differences in miR-200c expression between the two groups were analyzed. Results The transplantation was successful in both groups, and the hematopoietic function was restored. The recovery time was 18 days, among which 33 patients developed aGVHD and 18 patients did not develop aGVHD, with an incidence of 64.71%. The expression of miR-200c in experimental group was lower than that in control group before transplantation and 7, 14, and 72 d after transplantation (P＜0.05). MiR-200c in peripheral blood after the occurrence of aGVHD was significantly lower than that before the occurrence(P＜0.001). Compared with aGVHD Ⅱ, the expression of miR-200c in peripheral blood of aGVHD Ⅱ patients was down-regulated (P＜0.05); as compared with aGVHD Ⅲ patients, the expression of miR-200c in peripheral blood of aGVHD Ⅲ patients was down-regulated (P＜0.001); the 2-year survival rate in the high expression group of miR-200c was higher than that in the low expression group (P＜0.05). Conclusions The reduced level of miR-200c is associated with the occurrence of aGVHD after allogeneic hematopoietic stem cell transplantation. With the increase of the severity of aGVHD the expression level of miR-200c is decreased, and the survival rate of patients with low miR-200c expression is low, so the expression of miR-200 is a potential marker for early diagnosis and prediction of aGVHD.

Key words: acute graft-versus-host disease, miR-200c, allogeneic hematopoietic stem cell transplantation, prognosis

中图分类号:

R457.7

武坤, 聂波, 李云涛, 杨金荣, 程沈菊, 李艳红, 史明霞. 外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用[J]. 基础医学与临床, 2022, 42(6): 871-875.

WU Kun, NIE Bo, LI Yun-tao, YANG Jin-rong, CHENG Shen-ju, LI Yan-hong, SHI Ming-xia. Peripheral blood miR-200c level predicts the occurence of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation[J]. Basic & Clinical Medicine, 2022, 42(6): 871-875.

参考文献

[1] Helbig G,Koclga A,Woniczka K, et al. Long-term outcome of autologous hematopoietic stem cell transplantation (AHSCT) for acute myeloid leukemia (AML)-single center retrospective analysis[J]. Pathol Oncol Res, 2018, 24:469-475.
[2] 尹琎, 曹阳, 周剑峰,等. 外周血半乳糖凝集素9水平对异基因造血干细胞移植急性移植物抗宿主病的预测作用[J]. 中华血液学杂志, 2020, 41:23-27.
[3] Da Costa LNG,Costa-Lima C,De Meirelles LR, et al. Association between histopathological alterations and diarrhea severity in acute intestinal graft-versus-host disease[J]. Medicine, 2018, 97:e0600.doi:10.1097/MD.0000000000010600.
[4] Qian C,Yan W,Li T, et al. Differential expression of miR-106b-5p and miR-200c-3p in newly diagnosed versus chronic primary immune thrombocytopenia patients based on systematic analysis[J]. Cell Physiol Biochem, 2018, 45:301-318.
[5] 乔良伟, 曲青山, 李明. LncRNA-ATB通过调节miR-200c表达对肾移植大鼠急性排斥反应的影响[J]. 吉林大学学报:医学版, 2020,46:955-962.
[6] 王方, 邓建川. 异基因造血干细胞移植后急性移植物抗宿主病预防方法研究进展[J]. 检验医学与临床, 2018, 15:142-146.
[7] Gong R,Lv X,Liu F. miRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1[J]. Cell Mol Biol Lett, 2018, 23:16.doi:10.1186/s11658-018-0083-3.
[8] 赵伟, 李晓明. 被转化生长因子β活化的长链非编码RNA对人淋巴瘤Raji细胞增殖、周期及凋亡的影响[J]. 中国现代医学杂志, 2017, 27:18-23.
[9] Szmit Z, Kałwak K, Król A, et al. Premature cyclos-porine cessation and TBI-containing conditioning regimen increase the risk of acute GvHD in children undergoing unrelated donor hematopoietic stem cell transplantation[J]. Adv Clin Exp Med, 2019, 28:1185-1192.
[10] 王飞雁, 高春记. 急性移植物抗宿主病的诊断性生物学标记物研究进展[J]. 中国实验血液学杂志, 2017, 25:281-285.
[11] Ureña-Peralta JR, Alfonso-Loeches S, Cuesta-Diaz CM, et al. Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex[J]. Sci Rep, 2018, 8:15913. doi: 10.1038/s41598-018-34277-y.
[12] Xu R,Zhu X,Chen F, et al. LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells[J]. Cancer Cell Int, 2018, 18:41. doi: 10.1186/s12935-018-0540-0.
[13] 胡彬,付伟,黄斯勇,等.异基因造血干细胞移植后血浆microRNA的表达与急性移植物抗宿主病的相关性研究[J]. 中国实验血液学杂志, 2016, 3:827-832.
[14] 常琳,毛玉兰,黄茂华, 等.AFP阴性肝癌患者血清miR-451,miR-21与miR-200c的差异表达及价值分析[J]. 肝脏, 2019, 24:929-931.

[1]	李顺乐, 李蓉, 田亚亚, 冉小丽, 赵延培, 徐蒙. 血清KLF5和actinin-4水平与肝细胞肝癌肝动脉化疗栓塞术治疗预后的关系[J]. 基础医学与临床, 2024, 44(9): 1284-1289.
[2]	侯楠, 刘源, 高俊, 王晶, 袁萌. 全血NPM1、MCP-1和肠道菌群与胃癌进展及预后相关[J]. 基础医学与临床, 2024, 44(8): 1137-1142.
[3]	操辰新, 唐辉, 耿瑞璇, 郭伏平, 白春梅, 王颖轶, 李太生. 循环CD4⁺CD45RA⁺CD62L⁺ T细胞与接受EGFR-TKI治疗的转移性非小细胞肺癌预后相关[J]. 基础医学与临床, 2024, 44(5): 658-664.
[4]	傅晨, 李平. 重型再生障碍性贫血治疗的研究进展[J]. 基础医学与临床, 2024, 44(5): 719-723.
[5]	丁飞, 王洒, 黄常新. 非小细胞肺癌患者血清CA211水平和NK细胞数与预后相关[J]. 基础医学与临床, 2024, 44(2): 180-184.
[6]	张伟, 张振, 杨连任, 梁伟. 肺癌7项抗体水平与NSCLC患者化疗效果及预后的关系[J]. 基础医学与临床, 2024, 44(10): 1383-1387.
[7]	周昕羽, 汤继宏, 肖潇, 冯隽, 杨乐天, 徐欢, 武银银. 儿童急性B淋巴细胞白血病合并化疗诱导周围神经病变的临床特点及预后分析[J]. 基础医学与临床, 2024, 44(10): 1394-1399.
[8]	依马木买买提江·阿布拉, 帕哈尔丁·白克热, 易超, 佟庆. 血浆hsa_circ_005230在原发性肝细胞癌诊断和预后评估中的临床价值[J]. 基础医学与临床, 2023, 43(9): 1417-1422.
[9]	贡子琦, 吴晓雯, 郭倩, 郭军, 孔燕. PTEN突变对黏膜黑色素瘤患者临床病理特征及预后的影响[J]. 基础医学与临床, 2023, 43(9): 1341-1345.
[10]	张永梅, 张志敏, 周洁, 潘志兰, 冯丽倩, 杨彦. LncRNA CBR3-AS1在多发性骨髓瘤中的表达及临床意义[J]. 基础医学与临床, 2023, 43(6): 948-952.
[11]	薛剑超, 王亚东, 李博文, 刘新宇, 梁乃新, 李单青. DNA甲基化在肺癌发生及预后中作用的研究进展[J]. 基础医学与临床, 2023, 43(3): 514-518.
[12]	谢晓婷, 张雷, 张莉, 董凤, 刘颖, 李光华, 杨兴. ASH2L在幽门螺旋杆菌感染的人胃癌细胞系中的表达及临床意义[J]. 基础医学与临床, 2023, 43(3): 367-373.
[13]	李雨喋, 王宏宇, 韩松, 李俊发. 激活素A通过少突胶质细胞ACVR1C改善缺血性卒中小鼠神经功能的预后[J]. 基础医学与临床, 2023, 43(3): 380-385.
[14]	王芳芳, 曹慧媛, 汪婧, 王宁, 黄国良. 上调miR-200c-5p的表达抑制人结直肠癌细胞系SW480增殖[J]. 基础医学与临床, 2023, 43(2): 241-245.
[15]	陆文琪, 万琳. 内皮损伤在移植物抗宿主病发生发展中作用的研究进展[J]. 基础医学与临床, 2023, 43(11): 1728-1732.

外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用

Peripheral blood miR-200c level predicts the occurence of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价